Request Demo
Last update 08 May 2025
CAR1922T2 T cells(Tongji Hospital Tongji Medical College of HUST)
Last update 08 May 2025
Overview
Basic Info
Drug Type CAR-T |
Synonyms Novel TLR2-Containing CAR-T Cells Targeting CD19 and CD22(Tongji Hospital Tongji Medical College of HUST), Targeting CD19 and CD22 with CAR-T cells(Tongji Hospital Tongji Medical College of HUST) |
Target |
Action modulators |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators), CD22 modulators(CD22 modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with CAR1922T2 T cells(Tongji Hospital Tongji Medical College of HUST)NCT06879262
Clinical Study of Novel TLR2-Containing CAR-T Cells Targeting CD19 and CD22 for Refractory/Relapsed B-Cell Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma
100 Clinical Results associated with CAR1922T2 T cells(Tongji Hospital Tongji Medical College of HUST)
Login to view more data
100 Translational Medicine associated with CAR1922T2 T cells(Tongji Hospital Tongji Medical College of HUST)
Login to view more data
100 Patents (Medical) associated with CAR1922T2 T cells(Tongji Hospital Tongji Medical College of HUST)
Login to view more data
100 Deals associated with CAR1922T2 T cells(Tongji Hospital Tongji Medical College of HUST)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Burkitt Lymphoma | Phase 1 | - | 15 Mar 2025 | |
| Pre B-cell acute lymphoblastic leukemia | Phase 1 | - | 15 Mar 2025 | |
| Refractory B Acute Lymphoblastic Leukemia | Phase 1 | - | 15 Mar 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free